Results 131 to 140 of about 902,007 (283)

History of the Official Journal Published by the Korean Society of Pathologists: From the [PDF]

open access: yesJournal of Pathology and Translational Medicine, 2017
Se Hoon Kim, Chong Jai Kim, SoonWon Hong
doaj   +1 more source

Interpreting the effects of DNA polymerase variants at the structural level

open access: yesMolecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi   +7 more
wiley   +1 more source

Literature reviews vs systematic reviews

open access: yesAustralian and New Zealand Journal of Public Health, 2015
Priscilla Robinson, John Lowe
doaj   +1 more source

[Letter from The Kiplinger Editors, July 22, 1988]

open access: yes, 1988
Letter from the Kiplinger Editors, on July 22, 1988, discussing the growth of new business locations and expansions in Texas in 1989.
The Kiplinger Editors
core  

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Biodiversity, taxonomy and metagenomics

open access: yesThe European Zoological Journal, 2017
Ettore Olmo, Ferdinando Boero
doaj   +1 more source

Q&As - A Conversation with the Editors [PDF]

open access: yes
A conversation piece among the guest editors on their experience of collaborating between two Special Interest Groups for this Special Issue of the ...
Kiu Sum   +3 more
core  

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Home - About - Disclaimer - Privacy